NanoPhoria Bioscience raises record-breaking €83.5M Series A to advance heart failure therapy and expand nano-delivery platform
NanoPhoria Bioscience, a next-generation biotech developing inhalable cardiovascular therapies, has raised €83.5 million in a landmark Series A round — the largest ever for an Italian biotech.

The best Articles in our Network